Phathom Pharmaceuticals

Contributing Author

Recent Articles by Phathom Pharmaceuticals

Oct-25	Phathom Pharmaceuticals Announces Publication of Data from Phase 3 pHalcon-NERD-301 Study Showing VOQUEZNA (vonoprazan) Improved Nocturnal GERD Symptoms in Patients with Non-Erosive Reflux Disease PHAT GlobeNewswire
Oct-23	Phathom Pharmaceuticals to Highlight VOQUEZNA (vonoprazan) at the American College of Gastroenterology (ACG) 2025 Annual Scientific Meeting PHAT GlobeNewswire
Oct-20	Phathom Pharmaceuticals to Report Third Quarter 2025 Financial Results and Provide Business Update on Thursday, October 30, 2025 PHAT GlobeNewswire
Oct-06	Phathom Pharmaceuticals Appoints Sanjeev Narula as Chief Financial and Business Officer PHAT GlobeNewswire
Aug-25	Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences PHAT GlobeNewswire
Aug-20	Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder's Ownership Following Administrative Change to 13D Filing PHAT GlobeNewswire
Aug-07	Phathom Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Updates PHAT GlobeNewswire
Jul-28	Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025 PHAT GlobeNewswire
Jun-23	Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PHAT GlobeNewswire
Jun-23	Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary PHAT GlobeNewswire
Jun-16	Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA (vonoprazan) Tablets Through May 3, 2032 PHAT GlobeNewswire
Jun-06	Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA (vonoprazan) Tablets through May 3, 2032 PHAT GlobeNewswire
May-15	Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences PHAT GlobeNewswire
May-01	Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PHAT GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.